PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
AIDS. Author manuscript; available in PMC Jan 18, 2012.
Published in final edited form as:
PMCID: PMC3261071
NIHMSID: NIHMS348865
HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy
Steven J. Reynolds,ab Frederick Makumbi,c Gertrude Nakigozi,d Joseph Kagaayi,d Ronald H. Gray,e Maria Wawer,e Thomas C. Quinn,ab and David Serwaddac
aNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda
bJohns Hopkins University School of Medicine, Baltimore, Maryland, USA
cMakerere University School of Public Health, Kampala
dRakai Health Sciences Program, Kalisizo, Uganda
eJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
Correspondence to Steven J. Reynolds, 2190 Kampala Place, Dulles, VA 20189, USA. sjr/at/jhmi.edu
Objective
To evaluate the impact of antiretroviral therapy (ART) on HIV-1 transmission rates among HIV-1 discordant couples in Rakai, Uganda.
Design
Observational cohort study.
Methods
HIV-1 discordant couples were retrospectively identified between 2004 and 2009. Study participants underwent annual screening for HIV-1 and were interviewed to evaluate risk behaviors. Participants were offered voluntary counseling and testing and provided with risk reduction counseling. Free ART was offered to participants with a CD4 cell count of 250 cells/μl or less or WHO stage IV disease. HIV-1 incidence and sexual risk behaviors were compared before and after the HIV-1-positive index partners started ART.
Results
Two hundred and fifty HIV-1 discordant couples were followed between 2004 and 2009 and 32 HIV-1-positive partners initiated ART. Forty-two HIV-1 transmissions occurred over 459.4 person-years prior to ART initiation, incidence 9.2/100 person-years [95% confidence interval (CI) 6.59–12.36]. In 32 couples in which the HIV-1 index partners started ART, no HIV-1 transmissions occurred during 53.6 person-years. The 95% CI for the incidence rate difference was −11.91 to −6.38 (P=0.0097). Couples reported more consistent condom use during ART use, but there was no significant difference in the number of sexual partners or other risk behaviors. Viral load was markedly reduced in persons on ART.
Conclusion
HIV-1 transmission may be reduced among HIV-1 discordant couples after initiation of ART due to reductions in HIV-1 viral load and increased consistent condom use.
Keywords: antiretroviral, discordant couples, HIV transmission, HIV-1
Antiretroviral drugs have proven efficacy in the prevention of mother-to-child transmission of HIV-1 and may play a role in the prevention of HIV-1 transmission in HIV-1 discordant couples. Viral load is the major determinant governing the risk of sexual transmission in HIV-1 discordant couples and, therefore, effective ART should dramatically reduce transmission rates [1]. Preliminary evidence from observational studies on heterosexual populations and MSM suggests that when ART is taken effectively, the risk of HIV-1 transmission to HIV-1-negative partners is greatly reduced [2,3].
Free ART programs were initiated in Uganda in 2004 coinciding with increased donor resources for HIV/AIDS treatment programs. We began delivering free ART in our rural population in the Rakai district, southwestern Uganda in June 2004 through a decentralized program of 17 mobile clinics. Here we report the rates of HIV-1 transmission among HIV-1 discordant couples in the period prior to ART initiation compared to the period after treatment began.
HIV-1 discordant couples were identified through the Rakai Community Cohort study (RCCS), which conducts an annual census, health and behavioral survey, and HIV-1 screening among 15 000 individuals aged 15–49 years in 50 villages in rural Rakai district, southwestern Uganda. All RCCS participants provided written informed consent for study participation, including permission to identify married/consensual partners; the RCCS was approved by the western Institutional Review Board (IRB), the Uganda Virus Research Institute Science and Ethics Committee, and the Uganda National Council for Science and Technology. All study participants were offered voluntary HIV-1 testing and individual and couples' counseling. All participants were also counseled on HIV-1 prevention methods through community messages and individual counseling sessions emphasizing abstinence, being faithful, and using condoms, offered by trained HIV-1 counselors.
As of June 2004, the Rakai Program has offered free ART to Rakai district residents, including RCCS participants, who have CD4+ T-cell counts of 250 cells/μl or less or WHO stage IV disease. All HIV-1-infected RCCS participants were screened for ART eligibility every 6 months and started on ART if eligible by CD4+ cell or clinical criteria. To date, the program has provided ART to over 2100 individuals. For this analysis, we include RCCS data collected in four survey rounds between 2004 and 2009. HIV-1 discordant couples were identified retrospectively for this analysis in which HIV-1 incidence and HIV-1 risk behaviors of the HIV-1-uninfected partners were compared between survey rounds before and after the HIV-1 index partners were started on ART.
All married participants were identified and retrospectively linked to their spouses, including those in polygamous unions. Couple HIV-1 status was then determined at each visit, and couples were defined as HIV-1 discordant if one member was initially HIV-1-infected and the other uninfected. The first visit at which HIV-1 discordance was determined was classified as the baseline visit for this analysis. At both baseline visit and subsequent follow-up, we linked the HIV-1-positive partner to the Rakai Health Sciences ART service dataset to ascertain whether the HIV-1-positive person was on ART and date of ART initiation. The HIV-1-uninfected person was followed until seroconversion, or censored at the time of marital dissolution due to death, divorce/separation, outmigration, or last survey visit. We estimated person-time of follow-up in years as the duration of time between visits. If seroconversion occurred, we assumed infection occurred in mid-follow-up interval and ascribed half the person-time for this interval. We also estimated person-time exposure for those HIV-1-negative individuals whose HIV-1-positive partners started ART using the date of ART initiation. Such individuals could contribute both periods of exposure time before or after ART initiation, enabling us to estimate the incidence of HIV-1 transmission among the initially negative partners prior to and after their infected partner was on ART.
Laboratory methods
At each survey round, HIV-1 was ascertained using two different enzyme immunoassays (EIA; Vironostika HIV-1; Organon Teknika, Charlotte, North Carolina, USA, and Cambridge Biotech; Worcester, Massachusetts, USA), with western blot confirmation of all discordant EIAs and of all HIV-1 seroconverters (HIV-1 WB; Bio-Merieux–Vitek, St Louis, Missouri, USA). HIV-1 viral load testing was performed at baseline and at 6 monthly follow-up visits for participants who started on ART using the Roche monitor version 1.5 assay (Roche Diagnostics, Indianapolis, Indiana, USA).
Statistical analysis
We estimated HIV-1 incidence per 100 person-years as the number of new HIV-1 cases divided by the total person-years of follow-up, stratified by ART periods of nonuse and use. We used generalized linear models (GLMs) with a Poisson distribution and a log link function, with robust variance estimates for multiple observations on the same individual, to estimate the incidence rate ratios (IRRs) and the 95% confidence intervals (95% CI) of HIV-1 transmission during ART relative to the non-ART periods. We adjusted for the HIV-1-negative partner's sexual behaviors in a multivariable Poisson regression model. Statistical analyses used STATA software package version 9.2 (College Station, Texas, USA).
In the period between 2004 and 2009, when free ART became available in the Rakai program, 250 HIV-1 discordant couples were identified among whom 32 HIV-1-positive index partners were started on ART. Data from four survey rounds corresponding to 349 observation intervals were included in this analysis. Baseline characteristics of the HIV-1-negative partners in the discordant couple cohort are given in Table 1. Fifty-eight percent (145/250) of couples had a male index positive partner. Consistent condom use with any partner was 4.0%, and alcohol use before sex with any partner was common and reported by 40.4% of HIV-1-negative partners. In 20.0% of couples, HIV-1-negative husbands reported more than one wife (i.e. polygamous unions). The median [interquartile range (IQR)] follow-up time before ART initiation was 1.57 years (1.42–1.72) and median follow-up after ARTwas 1.54 years (1.00–1.76). During 308 observation intervals before ART exposure, 42 HIV-1 transmissions occurred over 459.3 person-years, with a transmission rate of 9.2/100 person-years [95% CI (6.59–12.36)]. During 41 periods after the 32 HIV-1 index partners received ART, no HIV-1 transmissions occurred over 53.6 person-years. The 95% CI for the incidence rate difference was −11.91 to −6.38 (P=0.0097).
Table 1
Table 1
Enrolment characteristics of HIV-1-negative partner in discordant relationship.
There were no statistically significant differences in gender, age, number of sexual partners over the past 12 months, self-reported genital ulcer disease (GUD), or male partner's circumcision status between periods before and after the positive partners started on ART (Table 2). HIV-1-negative partners reported more nonmarital relationships during periods after the positive partner was started on ART, but this was not statistically significant. Consistent condom use with any partner increased significantly from 14.3% prior to ART use to 53.7% after initiation of ART (P < 0.0001). Coital frequency declined after ART initiation, although not statistically significant (Table 2, P=0.081).
Table 2
Table 2
Sexual behaviors by period and HIV-1-positive partner's antiretroviral therapy status among HIV-1 discordant couples.
Viral load monitoring was done every 6 months during follow-up for clients started on ART. At 6 months, of 28 partners with an available viral load, 20 (71.4%) were below the limit of detection (<400 copies/ml) and the remaining eight were below the limit 2000 copies/ml. At 12 months, 85.2% (23/27) had an available viral load less than 400 copies/ml with the remaining four having viral loads ranging from 2293 to 672 513 copies/ml. All 28 clients with an available viral load at 24 months were below the limit of 400 copies/ml.
Antiretroviral therapy may have reduced the risk of transmission of HIV-1 among discordant couples in rural Uganda. Although there was a significant increase in consistent condom use following ART initiation (Table 2), the reduction in risk was most likely due to the direct reduction in HIV-1 viral load in the HIV-1-positive partners on ART. The findings are consistent with earlier studies showing that HIV-1 viral load is the most important determinant of HIV-1 transmission risk among discordant couples, with other observational studies reporting a reduction in transmission among HIV-1 discordant couples with ART [1,2,4,5]. These findings add to the growing body of evidence supporting the use of ART for HIV-1 prevention.
This observational study has several limitations. The number of couples started on ART during our study was small, which limited study power. We cannot differentiate between the effects of increased consistent condom use and the effects of ART on HIV viral load, which both occurred during the period of observation. There may have been a component of social desirability in the reported condom use among couples wherein the index positive partner was receiving ART. The lack of randomization of couples in our study could lead to bias due to unmeasured differences between periods before and after index positive partners were started on ART. Finally, adherence counseling and support are key components of the Rakai Health Sciences Program (RHSP) ART program and likely contributed to the good virologic treatment responses observed and the absence of HIV-1 transmission during periods on ART.
Ongoing studies such as the HIV-1 Prevention Trials Network 052 study will test the hypothesis that ART can prevent HIV-1 transmission among HIV-1 discordant couples [6]. Our data provide preliminary evidence to support this hypothesis among rural Ugandans participating in an ongoing cohort study and receiving free ART.
Acknowledgements
The authors would like to thank the Rakai Health Sciences Program (RHSP) clients and study staff. This study was supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases and in part by grant number R01 HD 050180 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAID or NICHD. All authors contributed to study design and manuscript writing. S.J.R., F.M., G.K., J.K., and D.S. contributed to study implementation and data collection. F.M. performed statistical analyses.
Footnotes
The study was presented in part at the 16th Conference on Retroviruses and Opportunistic Infectious, Montreal, 2009, abstract 52a.
1. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342:921–929. [PubMed]
2. Castilla J, Del RJ, Hernando V, Marincovich B, Garcia S, Rodriguez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr. 2005;40:96–101. [PubMed]
3. Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004;18:81–88. [PMC free article] [PubMed]
4. Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, Were W, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS. 2006;20:85–92. [PubMed]
5. Donnell D, Kiarie J, Thomas K, Baeten J, Lingappa J, Cohen C, et al. ART and risk of heterosexual HIV-1 transmission in HIV-1 serodiscordant African couples: a multinational prospective study. 17th Conference on Retroviruses and Opportunistic Infections.2010.
6. [Accessed 10 November 2010];HIV Prevention Trials Network, HPTN 052. http://www.hptn.org/research_studies/hptn052.asp.